You are here
Clinical Trials: Heart Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Biological: allogeneic human mesenchymal stem cells (hMSCs); Other: Placebo
Sponsors: Joshua M Hare; United States Department of Defense; The University of Texas Health Science Center, Houston
Not yet recruiting
Interventions: Biological: allogeneic human mesenchymal stem cells (hMSCs); Other: Placebo
Sponsors: Joshua M Hare; United States Department of Defense; The University of Texas Health Science Center, Houston
Not yet recruiting
Condition: Heart Failure
Intervention: Biological: EHM implantation
Sponsors: University Medical Center Goettingen; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK); University Medical Center Freiburg
Not yet recruiting
Intervention: Biological: EHM implantation
Sponsors: University Medical Center Goettingen; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK); University Medical Center Freiburg
Not yet recruiting
Condition: Respiratory Tract Diseases
Intervention: Drug: Stem Cell Product
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Intervention: Drug: Stem Cell Product
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Condition: Acute Myocardial Infarction
Intervention: Biological: Mesenchymal Stem Cells
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Intervention: Biological: Mesenchymal Stem Cells
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Condition: Heart Failure
Intervention: Other: Exercise Training Program
Sponsors: Centro Hospitalar do Porto; Universidade do Porto; Aveiro University
Recruiting
Intervention: Other: Exercise Training Program
Sponsors: Centro Hospitalar do Porto; Universidade do Porto; Aveiro University
Recruiting
Condition: Heart Attack
Intervention: Drug: PEP in Acute Myocardial Infarction
Sponsor: Paul G. Stalboerger
Not yet recruiting
Intervention: Drug: PEP in Acute Myocardial Infarction
Sponsor: Paul G. Stalboerger
Not yet recruiting
Condition: Coronavirus
Intervention: Biological: MSCs-derived exosomes
Sponsors: Ruijin Hospital; Shanghai Public Health Clinical Center; Wuhan Jinyintan Hospital, Wuhan, China; Cellular Biomedicine Group Ltd.
Not yet recruiting
Intervention: Biological: MSCs-derived exosomes
Sponsors: Ruijin Hospital; Shanghai Public Health Clinical Center; Wuhan Jinyintan Hospital, Wuhan, China; Cellular Biomedicine Group Ltd.
Not yet recruiting
Condition: Patients
Interventions: Other: Incremental cycling test (ICT); Other: Constant load cycling test (CET); Other: Incremental respiratory muscle test (IncRMET); Other: Incremental quadriceps muscle test (IncQMT); Other: Respiratory muscle training like interventions
Sponsor: Swiss Federal Institute of Technology
Recruiting
Interventions: Other: Incremental cycling test (ICT); Other: Constant load cycling test (CET); Other: Incremental respiratory muscle test (IncRMET); Other: Incremental quadriceps muscle test (IncQMT); Other: Respiratory muscle training like interventions
Sponsor: Swiss Federal Institute of Technology
Recruiting
Condition: Acute Myocardial Infarction
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Recruiting
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Recruiting
Condition: Coronary Artery Disease
Intervention: Biological: MCRcI® stem cells
Sponsors: Honya Medical Inc; Chang Gung Memorial Hospital
Recruiting
Intervention: Biological: MCRcI® stem cells
Sponsors: Honya Medical Inc; Chang Gung Memorial Hospital
Recruiting
